APA način citiranja

Chase, A., Bryant, C., Score, J., Haferlach, C., Grossmann, V., Schwaab, J., . . . Cross, N. C. (2013). Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements. Ferrata Storti Foundation.

Čikaški stil citiranja

Chase, Andrew, Catherine Bryant, Joannah Score, Claudia Haferlach, Vera Grossmann, Juliana Schwaab, Wolf-Karsten Hofmann, Andreas Reiter, i Nicholas C.P Cross. Ruxolitinib As Potential Targeted Therapy for Patients With JAK2 Rearrangements. Ferrata Storti Foundation, 2013.

MLA način citiranja

Chase, Andrew, et al. Ruxolitinib As Potential Targeted Therapy for Patients With JAK2 Rearrangements. Ferrata Storti Foundation, 2013.